Buy & Sell Nuwellis Inc (NUWE) – Nuwellis Inc Price Today
Key Stats
- $1.62MMarket Cap
- TechnologySector
- -89.88%3M Drawdown
- -$194.54KEnterprise Value
- -Dividend Yield
- 50% Buy | 50% SellTrading Activity
- 10 daysTypical Hold Time
Nuwellis Inc (NUWE) is currently valued at a market capitalization of $1.62M, with an enterprise value of -$194.54K. Over the past 52 weeks, Nuwellis Inc has traded between a low of $0.12 and a high of $15.95, highlighting its annual price range. Over the past three months, Nuwellis Inc has recorded a drawdown of -89.88%, reflecting recent price volatility. On average, investors hold Nuwellis Inc for approximately 10 days, indicating typical investor behavior on the platform.
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Most Recent News
ASE Technology sees AI chip demand boost but insider selling and high valuation raise caution.
ASE Technology Holding Co Ltd reported strong growth driven by demand for AI chip packaging, with gross margins rising to 20.1% from 16.8% year-over-year. The company expects its advanced packaging revenue to exceed $3.5 billion in 2026, reflecting r...

Over 20 pharma firms actively develop 25+ drugs for acute kidney injury treatment, signaling strong pipeline growth.
More than 20 pharmaceutical companies are actively researching and developing over 25 drugs for acute kidney injury (AKI), a condition causing sudden kidney function decline. Key players like AstraZeneca and Akebia Therapeutics are advancing therapie...

Law firm probes fairness of shareholder deals in Dana, Roku, TruBridge, Affinity Bancshares sales
Halper Sadeh LLC is investigating whether shareholders of Dana Incorporated, Roku, TruBridge, and Affinity Bancshares are receiving fair treatment in their companies' proposed sales. The firm highlights potential conflicts where insiders might gain b...
